Sven Dethlefs, EVP Global Marketing&Portfolio at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), bought 2,000 shares at $21.92 ($44K) on 2018-08-03, disclosed to the SEC on 2018-08-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| TEVA | SELL | 2022-03-08 | $132K | — | Filing → |
| TEVA | SELL | 2022-03-02 | $40K | — | Filing → |
| TEVA | SELL | 2022-02-10 | $37K | — | Filing → |